Medmen: Cantor Reiterates Ratings After Call With Management

On September 23, Medmen Enterprises (CSE: MMEN) reported their fiscal fourth quarter financial results. The company reported revenue of $42 million, up 18.5% quarter over quarter and 55.4% year over year. The company saw gross margins come in at 46.9%, up from 40.5% last quarter.

On October 5th, Cantor Fitzgerald reiterated their $0.28 12-month price target and Neutral rating after a call with management. They say that the although comps for this quarter were depressed, their sales in California, Nevada, and Arizona which grew at rates of 24%, 44%, and 17% respectively, were noteworthy.

They write, “Sales and EBITDA trends continue to improve as the company’s turnaround gains traction.” Medmen is aiming to operate premier retail cannabis stores and provide customers with higher than normal experiences in their stores. Cantor says that the data shows that the results getting towards this experience is mixed with “revenue per store below the respective state averages in AZ, FL, and NV (about half the state avg in FL/NV), only inline in IL, and about 25% above in CA.”

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Below you can see Cantor’s updated estimates for Medmen.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Cineplex: Canaccord Lowers Target To $17 From $19

On February 11th, Cineplex Inc (TSX: CGX) reported its fourth quarter financial results. The company...

Tuesday, February 15, 2022, 05:17:00 PM

Galaxy Digital Sees BMO Lift Price Target To $35 After Q4 Results

On April 3rd, BMO raised Galaxy Digital Holdings’ (TSX: GLXY) 12-month price target from $32...

Wednesday, April 6, 2022, 05:03:00 PM

Valens Company: Canaccord Warns Of Integration Risk Following Acquisitions

This week has been a busy one for The Valens Company (TSX: VLNS). On Tuesday,...

Friday, September 3, 2021, 03:40:00 PM

Canaccord Reiterates Ratings On Uranium Royalty Following Latest Purchase

On December 2nd, Uranium Royalty Corp (TSXV: URC) announced that they have entered into a...

Sunday, December 5, 2021, 12:56:00 PM

Curaleaf: Consensus Estimate Falls To $20.18 After Weak Guidance

On March 3rd, Curaleaf Holdings, Inc. (CSE: CURA) reported its fourth quarter and full year...

Friday, March 11, 2022, 04:20:00 PM